Abstract:This study characterizes glutathione (GSH) S-transferase (GST) isoenzymes of the liver and forestomach of the female A/J mouse and compares their specificities in catalyzing the conjugation of GSH with 7beta,8alpha-dihydroxy-9alpha,10alpha-oxy-7,8,9, 10-tetrahydrobenzo[a] pyrene (anti-BPDE), the ultimate carcinogenic metabolite of benzo[a]pyrene (BP). The GST activity in female A/J mouse liver was expressed by a minimum of seven isoenzymes which arose from different homo- or heterodimeric combinations of at least two alpha class (designated as alpha1 and alpha4), four micro class (micro1 to micro4), and one pi class GST subunit. The GST isoenzyme composition of A/J mouse forestomach appeared to be different from that of the liver. For example, while GST isoenzymes containing micro3 and micro4 type subunits were selectively expressed in the liver, an alpha class heterodimeric GST isoenzyme (containing alpha2 and alpha3 subunits) was expressed in the forestomach but could not be detected in the liver. The (+)-anti-BPDE appeared to be a better substrate than the (-)-enantiomer for all GSTs, except for isoenzymes containing the alpha4 type GST subunit. The murine pi class GST isoenzyme displayed relativey higher specific activity toward (+)-anti-BPDE compared to other GSTs. The specific activities of mouse GSTs toward (+)-anti-BPDE were in the order of pi > micro > alpha. These results suggest that the pi class GST isoenzyme may play an important role in providing protection against BP-induced cancer. Therefore, it seems logical to postulate that the ability of a chemoprotector to increase the expression of GST pi may be an important determinant of its effectiveness against BP-induced cancer. To test the validity of this contention, we have determined the effects on hepatic and forestomach GST isoenzyme/subunit expression of three naturally occurring organosulfides (OSCs) from garlic, which significantly differ in their effectiveness against BP-induced forestomach cancer. Treatment of mice with diallyl sulfide (DAS) and diallyl trisulfide (DATS), which are potent inhibitors of BP-induced fore- stomach cancer in mice, resulted in a significant increase in hepatic and forestomach GST activity toward anti-BPDE. On the contrary, this activity was not increased in either organ by dipropyl sulfide (DPS), which is ineffective against BP-induced forestomach cancer. The chemopreventive efficacy of these OSCs correlated with their ability to increase the expression of GST pi. For example, DAS treatment resulted in approximate increases of 1.7- and 2.2-fold in hepatic and forestomach GST pi expression, respectively, over the control. Treatment of mice with DATS, which is a relatively more potent inhibitor of BP-induced forestomach cancer than DAS, resulted in about 3.8- and 3.2-fold increases, respectively, in hepatic and forestomach GST pi expression over the control. On the contrary, the expression of hepatic and forestomach GST pi was increased only marginally (10-20%) upon DPS administration. In conclusion, the results of the present study suggest that induction of GST pi can be used as a bioassay for screening potential inhibitors of BP-induced cancer.

Gender Related Differences in ATP‐dependent Transport of Dinitrophenyl‐glutathione Conjugate Across Murine Canalicular Liver Plasma Membrane

Hepatic glutathione and glutathione S-conjugate transport mechanisms.

Endocrine Regulation of Gender-Divergent Mouse Organic Anion-Transporting Polypeptide (oatp) Expression

Differential Enantioselectivity of Murine Glutathione S-transferase Isoenzymes in the Glutathione Conjugation of Trans-3,4-dihydroxy-1, 2-Oxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene Stereoisomers.

Gender-related Differences in Susceptibility of A/J Mouse to Benzo[a]pyrene-Induced Pulmonary and Forestomach Tumorigenesis.

Effects of Aging on mRNA Profiles for Drug-Metabolizing Enzymes and Transporters in Livers of Male and Female Mice

Transport of amphipathic anions by human multidrug resistance protein 3

Gender Differences of Peripheral Plasma and Liver Metabolic Profiling in App/Ps1 Transgenic Ad Mice

Active Site Architecture of Polymorphic Forms of Human GlutathioneS-Transferase P1-1 Accounts for Their Enantioselectivity and Disparate Activity in the Glutathione Conjugation of 7β,8α-Dihydroxy-9α, 10α-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene

Mechanism of Differential Catalytic Efficiency of Two Polymorphic Forms of Human Glutathione S-transferase P1-1 in the Glutathione Conjugation of Carcinogenic Diol Epoxide of Chrysene.

Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions

Structural Determinants of Substrate Specificity Differences between Human Multidrug Resistance Protein (MRP) 1 (ABCC1) and MRP3 (ABCC3)

Gender-related Differences in Pharmacokinetics of Novel Prodrug of Triptolide MC002 in Rats

GlutathioneS-Transferases of Female A/J Mouse Liver and Forestomach and Their Differential Induction by Anti-carcinogenic Organosulfides from Garlic

An Alpha Class Mouse Glutathione S-Transferase with Exceptional Catalytic Efficiency in the Conjugation of Glutathione with 7β,8α-Dihydroxy-9α,10α-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene

Sex-specific differenceschanges in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease

Tissue Distribution Of Concentrative And Equilibrative Nucleoside Transporters In Male And Female Rats And Mice

Transport of Bile Acids, Sulfated Steroids, Estradiol 17- -D-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11)

Specificity of Murine Glutathione S-Transferase Isozymes in the Glutathione Conjugation of (-)-anti- and (+)-Syn-stereoisomers of Benzo[G]Chrysene 11,12-Diol 13,14-Epoxide

[Gender-Related Differences in Metabolism of the Enantiomers of Trans Tramadol and Trans O-demethyltramadol in Rat Liver Microsomes].

Cloning, Expression, and Biochemical Characterization of a Functionally Novel Alpha Class Glutathione S-transferase with Exceptional Activity in the Glutathione Conjugation of (+)-Anti-7,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene.